Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 5.88
(3.34%)
CNY 5.88
(3.34%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 327.87 Million CNY | 71.84% |
| 2022 | 190.8 Million CNY | 36.18% |
| 2021 | 140.11 Million CNY | 32.03% |
| 2020 | 106.12 Million CNY | -57.72% |
| 2019 | 250.98 Million CNY | 10.66% |
| 2018 | 226.81 Million CNY | -16.71% |
| 2017 | 272.3 Million CNY | -3.65% |
| 2016 | 282.6 Million CNY | 0.34% |
| 2015 | 281.64 Million CNY | -19.38% |
| 2014 | 349.35 Million CNY | 9.58% |
| 2013 | 318.81 Million CNY | 31.64% |
| 2012 | 242.19 Million CNY | 44.54% |
| 2011 | 167.56 Million CNY | 35.46% |
| 2010 | 123.7 Million CNY | 80.14% |
| 2009 | 68.66 Million CNY | 19.1% |
| 2008 | 57.65 Million CNY | 28.66% |
| 2007 | 44.81 Million CNY | 114.75% |
| 2006 | 20.86 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 74.92 Million CNY | 39.59% |
| 2024 Q2 | 53.68 Million CNY | -39.32% |
| 2024 Q1 | 88.45 Million CNY | -32.86% |
| 2023 Q1 | 80.17 Million CNY | 11.06% |
| 2023 Q4 | 131.74 Million CNY | 116.56% |
| 2023 FY | 327.87 Million CNY | 71.84% |
| 2023 Q3 | 60.83 Million CNY | 10.4% |
| 2023 Q2 | 55.1 Million CNY | -31.27% |
| 2022 Q4 | 72.19 Million CNY | 101.46% |
| 2022 Q1 | 57.63 Million CNY | 134.15% |
| 2022 Q2 | 25.14 Million CNY | -56.38% |
| 2022 Q3 | 35.83 Million CNY | 42.54% |
| 2022 FY | 190.8 Million CNY | 36.18% |
| 2021 FY | 140.11 Million CNY | 32.03% |
| 2021 Q4 | 24.61 Million CNY | -26.98% |
| 2021 Q1 | 57.23 Million CNY | 14752.77% |
| 2021 Q3 | 33.7 Million CNY | 37.28% |
| 2021 Q2 | 24.55 Million CNY | -57.1% |
| 2020 Q2 | 24.23 Million CNY | -54.02% |
| 2020 FY | 106.12 Million CNY | -57.72% |
| 2020 Q4 | 385.36 Thousand CNY | -98.66% |
| 2020 Q3 | 28.79 Million CNY | 18.83% |
| 2020 Q1 | 52.7 Million CNY | 23.47% |
| 2019 FY | 250.98 Million CNY | 10.66% |
| 2019 Q4 | 42.68 Million CNY | -22.8% |
| 2019 Q3 | 55.29 Million CNY | -32.04% |
| 2019 Q2 | 81.36 Million CNY | 13.6% |
| 2019 Q1 | 71.62 Million CNY | 715.42% |
| 2018 Q3 | 55.31 Million CNY | -33.8% |
| 2018 FY | 226.81 Million CNY | -16.71% |
| 2018 Q4 | -11.63 Million CNY | -121.04% |
| 2018 Q1 | 99.58 Million CNY | 1179.61% |
| 2018 Q2 | 83.55 Million CNY | -16.09% |
| 2017 Q1 | 90.69 Million CNY | 300.2% |
| 2017 Q3 | 70 Million CNY | -32.57% |
| 2017 Q4 | 7.78 Million CNY | -88.88% |
| 2017 FY | 272.3 Million CNY | -3.65% |
| 2017 Q2 | 103.81 Million CNY | 14.47% |
| 2016 Q1 | 83.11 Million CNY | 205.76% |
| 2016 Q3 | 68.48 Million CNY | -36.79% |
| 2016 Q4 | 22.66 Million CNY | -66.91% |
| 2016 FY | 282.6 Million CNY | 0.34% |
| 2016 Q2 | 108.34 Million CNY | 30.36% |
| 2015 FY | 281.64 Million CNY | -19.38% |
| 2015 Q4 | 27.18 Million CNY | -58.23% |
| 2015 Q3 | 65.08 Million CNY | -35.07% |
| 2015 Q2 | 100.23 Million CNY | 12.44% |
| 2015 Q1 | 89.14 Million CNY | 19.06% |
| 2014 Q4 | 74.87 Million CNY | -17.72% |
| 2014 Q3 | 91 Million CNY | -12.08% |
| 2014 Q2 | 103.5 Million CNY | 29.44% |
| 2014 FY | 349.35 Million CNY | 9.58% |
| 2014 Q1 | 79.96 Million CNY | 14.84% |
| 2013 Q1 | 68.35 Million CNY | 22.33% |
| 2013 FY | 318.81 Million CNY | 31.64% |
| 2013 Q4 | 69.63 Million CNY | -16.51% |
| 2013 Q3 | 83.39 Million CNY | -14.41% |
| 2013 Q2 | 97.43 Million CNY | 42.54% |
| 2012 Q1 | 50.8 Million CNY | 39.6% |
| 2012 Q2 | 71.37 Million CNY | 40.49% |
| 2012 Q3 | 64.13 Million CNY | -10.14% |
| 2012 Q4 | 55.87 Million CNY | -12.88% |
| 2012 FY | 242.19 Million CNY | 44.54% |
| 2011 Q2 | 48.68 Million CNY | 34.82% |
| 2011 FY | 167.56 Million CNY | 35.46% |
| 2011 Q4 | 36.39 Million CNY | -21.52% |
| 2011 Q1 | 36.11 Million CNY | 44.09% |
| 2011 Q3 | 46.37 Million CNY | -4.74% |
| 2010 Q1 | 16.11 Million CNY | -13.81% |
| 2010 Q4 | 25.06 Million CNY | -45.1% |
| 2010 Q3 | 45.65 Million CNY | 23.79% |
| 2010 FY | 123.7 Million CNY | 80.14% |
| 2010 Q2 | 36.87 Million CNY | 128.87% |
| 2009 Q3 | 20.26 Million CNY | 16.48% |
| 2009 Q4 | 18.69 Million CNY | -7.74% |
| 2009 FY | 68.66 Million CNY | 19.1% |
| 2009 Q2 | 17.39 Million CNY | 41.22% |
| 2009 Q1 | 12.31 Million CNY | -56.25% |
| 2008 Q4 | 28.15 Million CNY | 204.69% |
| 2008 FY | 57.65 Million CNY | 28.66% |
| 2008 Q3 | 9.24 Million CNY | 0.0% |
| 2007 FY | 44.81 Million CNY | 114.75% |
| 2006 FY | 20.86 Million CNY | 0.0% |